|
|
 |
Cerexa to be Acquired by
Forest Laboratories for $480 Million Plus Potential $100 Million
Milestone Payment
December 14, 2006
Concert Pharmaceuticals
Raises $48.5 Million in Series B Financing
November 30, 2006
Merck & Co., Inc. to
Acquire Sirna Therapeutics, Inc.
October 30, 2006
VaxInnate Secures $40
Million Series C Financing
October 25, 2006
Barrier Therapeutics, Inc.
to Raise $25 Million in Registered Direct Offering
September 15, 2006
Artisan Pharma, Inc. Raises $39 Million in a Series A
Financing
September 2, 2006
New Leaf Venture Partners
Announces $12 Million Financing in Tioga Pharmaceuticals
January 9, 2006
New Leaf Venture Partners
Announces $8.5 Million Financing in TransOral Pharmaceuticals
October 28, 2005
New Leaf Venture Partners
Announces $3.5 Million Financing in Direct Flow Medical
September 7, 2005
New Leaf Venture Partners
Announces $8 Million Investment in Cerexa's $50 Million
Financing; Investment is First from NLV Partners' Recently
Announced Fund Dedicated to Healthcare Technologies
August 23, 2005
|